Using FDG-PET to guide Hodgkin lymphoma treatment

In this interview, Peter Johnson, MD, of the University of Southampton in the United Kingdom, discusses the results of trials testing the role of FDG–positron emission tomography (PET) to direct therapy (escalation or de-escalation) for patients with both early and advanced Hodgkin lymphoma. Read more, and watch the video here.

Tags: Cancer PET Research Trials

About NMC  |  Products  |  Quote  |  News  |  Resources  |  Contact  |  Sitemap